Two distinct solubilized benzodiazepine receptors: differential modulation by ions

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Benzodiazepine receptors are crucial for neuronal inhibition.
• Type 1 and type 2 benzodiazepine receptors exhibit distinct pharmacological profiles.
• Understanding modulators of these receptors is key to comprehending their function.

Purpose of the Study:

• To investigate the effects of gamma-aminobutyric acid (GABA), divalent cations, and anions on solubilized type 1 and type 2 benzodiazepine receptors.
• To determine the specific mechanisms by which these substances modulate receptor binding.
• To explore the potential physiological relevance of these modulations.

Main Methods:

• Solubilization of type 1 and type 2 benzodiazepine receptors from cow brain.
• Assay of [3H]flunitrazepam binding in the presence of GABA, various divalent cations (Ca2+, Zn2+, Mn2+, Ba2+, Mg2+, Cu2+, Ni2+), and anions (Cl-, Br-, I-).
• Analysis of receptor affinity (Kd) and maximum binding capacity (Bmax) under different conditions.

Main Results:

• GABA stimulated [3H]flunitrazepam binding to both receptor subtypes.
• Divalent cations and anions (chloride, bromide, iodide) selectively stimulated solubilized type 2 receptors.
• Chloride and bromide primarily affected receptor affinity, while iodide influenced Bmax; divalent cations increased binding site numbers.
• GABA, calcium, and chloride demonstrated protective effects against heat inactivation, indicating linked binding sites.

Conclusions:

• GABA, divalent cations, and specific anions differentially modulate type 1 and type 2 benzodiazepine receptors.
• Physiological concentrations of calcium and chloride may influence type 2 receptor function and mediate benzodiazepine effects.
• The findings highlight the complex interplay between neurotransmitters and ions at benzodiazepine binding sites.